Craft

Cibus

Stock Price

$4.2

2024-10-29

Market Capitalization

$119.7 M

2024-10-29

Revenue

$3.6 M

FY, 2025

Cibus Summary

Company Summary

Overview
Cibus (formerly known as Calyxt) is a plant-based synthetic biology company that provides plant gene editing technologies. It offers the Rapid Trait Development System (RTDS), a gene editing technology to develop plant traits using conventional breeding. The company also provides the Trait Machine, a semi-automated precision breeding system.
Type
Public
Status
Active
Founded
2001
HQ
San Diego, CA, US | view all locations
Website
https://cibus.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Keith Walker, Director

    • Mark Finn, Director

      • Gerhard Prante, Vice Chairman

        • Jean-Pierre Lehmann, Director

          Operating MetricsView all

          Patents (US)

          16

          May, 2017

          Patents Pending (US)

          49

          May, 2017

          Patents (Foreign)

          65

          May, 2017

          LocationsView all

          4 locations detected

          • San Diego, CA HQ

            United States

            6455 Nancy Ridge Drive

          • New York, NY

            United States

            One Liberty Plaza 46th Floor

          • Roseville, MN

            United States

            2800 Mount Ridge Road

          • Breda, NB

            Netherlands

            Ceresstraat 13

          Cibus Financials

          Summary Financials

          Revenue (Q1, 2026)
          $1.7M
          Net income (Q1, 2026)
          ($21.2M)
          Cash (Q1, 2026)
          $30.3M
          EBIT (Q1, 2026)
          ($12.1M)
          Enterprise value
          $121.5M

          Footer menu